03-Jul-15 Despite China's ambitions for its pharmaceutical sector, it is likely to continue to depend on contributions from foreign companies for some time. Investment by big pharma companies in R&D in China is still in the early stages, but it, alongside other emerging world regions, holds out hope for reducing costs, market expansion, and reconfiguring the global drug development model. [image: Zhang Chengliang / China Daily]

02-Jul-15 IHH Healthcare, owner of Southeast Asia's largest private healthcare provider Parkway Pantai, has secured a license to establish and own 70% of Parkway Health Shanghai Intl Hospital Co Ltd in Shanghai. The remaining 30% of the company, which is licensed to provide multi-specialty hospital in-patient and out-patient services, is owned by IHH's partner Shanghai Hongxin Medical Investment Holding Co Ltd. [image: 15 Minute News]

30-Jun-15 The Chinese government will support domestic hospitals in promoting Chinese medicine worldwide, the Overseas Chinese Affairs Office of the State Council has said. It is encouraging domestic hospitals to foster ties with hospitals in other counties run by overseas Chinese and to set up Chinese medicine centres abroad. [image: UPI / Stephen Shaver]

18-Jun-15 The China-Australia Free Trade Agreement (ChAFTA) was officially signed on 17-Jun-15. ChAFTA increases Australian investors’ ability to own medical facilities either wholly or by majority JV, enables some Australian physicians to offer services in China, permits wholly Australian-owned aged care institutions, and promotes cooperation in the field of Traditional Chinese Medicine. [image: The Conversation]

18-Jun-15 Rising cardiovascular disease rates in China are being linked to rising obesity and demand for meat with high salt content. It is not junk food that is to blame, but oil- and salt-heavy foods such as hotpot. Even in Guangdong, known for its bland food, average salt intake is 9.1 grams per day, 82% higher than the WHO recommended amount. [image: China Daily Asia]